Work Experience

Dr. Sreedharan completed his MBBS from Trivandrum Medical College in 1995 and then
pursued DM in Medical Oncology, which he completed in 2001. With over 20 years of
experience in the field of oncology, he is a highly skilled clinician, specializing in
Gynaecological, Genitourinary, and Breast Oncology.

Dr. Sreedharan, a native from Trivandrum, started his career with Adyar Cancer Institute,
Chennai, and then moved to Lakeshore Hospital, Ernakulam, before joining MVRCCRI. He
has also worked as a consultant at the Kuwait Cancer Control Center in Kuwait. During his
career, he has treated numerous patients with different types of cancer and has received
widespread recognition for his work.

Apart from his clinical responsibilities, Dr. Sreedharan is also the Member Secretary of the
MVR Ethics Committee and an NABH accessor for Ethics committees and Clinical Trails. He is
actively involved in promoting ethical practices and ensuring that patients receive the
highest quality of care at MVRCCRI.

Gynaec oncology, Genito urinary oncology, Breast

• Interferon therapy for CML 1990-1998 Cancer institute Chennai experience –XV Asia Pacific Cancer conference 1999. OP23-2.
• Cutaneous plasmacytoma- J Assoc Physicians India 1997; 45 [10], 777.
• Subdural hematoma with spontaneous resolution- rare manifestation of idiopathic thrombocytopenic purpura- J Assoc Physicians India 2000,48(4), 432-434.
• ALL presenting as breast mass. – J Assoc Physicians India 2000; 48: 1212-1213.
• Bilateral primary non-Hodgkin’s lymphoma of the breast, XV APCC 1999. P3-032.
• Outcome of Germ cell tumor of ovary. Management with bleomycin, etoposide and cisplatinum, cancer institute Chennai experience XV APCC 1999. P3-033.
• Treatment of Carcinoma ovary with taxol – cancer institute Chennai experience XVAPCC,1999. P3-064.
• Promyelocytic leukaemia- excellent response to retinoic acid. Kerala Medical Journal Vol 38[4&5], 1997, 21-22.
• Occurrence of high-grade NHL following renal transplant-a case report.Indian Journal of Medical and Paediatric Oncology 2000; 21(1): 30-31.
• Intracardiac metastases from a testicular germ cell tumor. Journal of the Association of Physicians of India 2002; 50: 855.
• Insights into pathogenesis, newer therapies, and role of HDCT in multiple myeloma-CME Cancer institute August 2002.
• Role of hormonal therapy in breast cancer- ROI Tamilnadu state chapter conference,Chennai 2002
• Newer agents in CML and Cancer institute experience with Glivec- CME cancer institute April 2003.
• Ifosfamide Based Intensive MCP842 Protocol in diffuse Intermediate and High Grade Non-Hodgkin’s Lymphoma. Indian Journal of Medical and Paediatric Oncology 2003;24(3):5-8.
• Paediatric osteosarcoma- single institute experience- PEDICON 2009 HO/29[P]
• Chronic Neutrophilic Leukaemia: A Case Report and Review of Literature.
• Indian Journal of Medical and Paediatric Oncology 2004; 25(4) 46-48.
• MALT lymphomas- treated with chemotherapy or radiotherapy: clinical features,prognostic factors and survival. Gulf Journal of Oncology 2013; 14: 77-80.
• Analysis of neoadjuvant therapies in breast cancer with respect to pathological complete response, disease-free survival, and overall survival: 15 years follow-up data from Kuwait. Asia-Pacific Journal of Clinical Oncology 2013 Aug 12. doi:10.1111/ajco.12118.

• MBBS KERALA UNIVERSITY
• MD (GENERAL MEDICINE)
• DM (MEDICAL ONCOLOGY)
• MGR MEDICAL UNIVERSITY INDIA

NABH Assessor for ethics committees and clinical trials.